Lili Milani, M.D., Ph.D.

Lili MILANI, M.D., Ph.D., obtained her Ph.D. degree in molecular medicine from Uppsala University, Sweden, in 2009. Her main areas of research have been epigenetics and pharmacogenetics. She is actively involved in research projects focusing on stroke prevention and the role of rare and common genetic variants in adverse drug reactions.

Dr. Milani is vice director of the Institute of Genomics, University of Tartu, where her main responsibilities are directing research and scientific collaboration at the Estonian Genome Centre. She is also a Professor and Head of Pharmacogenetics and actively participating in preparing and implementing the national strategy for personalized medicine in Estonia in close collaboration with the Ministry of Social Affairs and Institute for Health Development.